Article info

Download PDFPDF

Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions

Authors

  1. Correspondence to Michel Michaelides, Moorfields Eye Hospital, London EC1V 9EL, UK; michel.michaelides{at}ucl.ac.uk
View Full Text

Citation

Guimaraes TACD, Georgiou M, Bainbridge JWB, et al
Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions

Publication history

  • Received February 27, 2020
  • Revised March 18, 2020
  • Accepted March 20, 2020
  • First published April 8, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.